This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
One virus can produce different clinical forms
Bovine herpesvirus 1 is associated with the respiratory syndrome called infectious bovine rhinotracheitis and with genital disease. In females, inflammation affects the vulva and vagina; in males, the penis and prepuce may be involved. The older coital-exanthema name describes a clinical presentation rather than a separate unrelated cattle virus.
The Friedrich-Loeffler-Institut reference laboratory distinguishes these forms. A herd may recognize the virus through respiratory illness, reproductive problems or testing rather than through every manifestation at once.
Do not confuse the cattle condition with equine coital exanthema. A similar name does not establish the same pathogen or justify transferring a horse disease explanation to cattle.
Genital lesions can make mating and urination uncomfortable
Inflamed mucosal surfaces may become reddened and develop small lesions that progress to erosions or ulcers. Females may carry the tail abnormally or show frequent attempts to urinate. Bulls can be reluctant to serve because contact with damaged tissue is painful.
The Merck BHV-1 discussion describes genital infection in both sexes. The findings still require examination: trauma, other genital infections and unrelated urinary problems can overlap.
Seek prompt veterinary help for painful swelling, inability to urinate normally, marked discharge or a bull that suddenly refuses service. A cow with fever, depression, respiratory difficulty or pregnancy loss needs assessment of that broader illness too. Do not inspect painful tissue by forcefully exposing or manipulating it.
Visible healing and viral clearance are different
After the initial infection, herpesvirus can persist in a latent state in neural tissue. WOAH’s IBR/IPV overview describes latency following genital infection in the sacral ganglia. An animal can look normal while retaining the infection.
Later reactivation can provide opportunities for spread. A healed mucosal lesion is therefore not a reliable certificate of freedom, and a buyer cannot judge status from the external genital appearance alone. The timing and interpretation of tests should fit the herd’s vaccination and infection history.
This is also why a short period of symptomatic treatment cannot be described as removing the virus for life. Relieving the present discomfort and managing long-term infection risk are different goals.
Breeding contact and semen can spread the virus
Natural service brings susceptible genital mucosa into direct contact with infected secretions and tissues. Merck also notes transmission without visible lesions and through semen from subclinically infected bulls. A symptom-free donor is not automatically a suitable semen source.
Temporarily stop mating affected cattle and obtain a veterinary plan for the exposed breeding group. Avoid transferring unassessed animals into a new group simply because the lesions have become less obvious. Appropriate disease-controlled semen and professional reproductive services can reduce risk when artificial insemination is used.
Also consider the herd’s wider BHV-1 status, rather than managing a genital lesion as an isolated wound. The same infection has consequences beyond the bull and the female most recently observed to mate.
Diagnosis should answer the current clinical question
The veterinarian examines the lesions and considers a suitable test to identify the virus or assess exposure. Antibody evidence can reflect infection or vaccination, depending on the assay and vaccine. A positive antibody result does not by itself prove that BHV-1 caused every current sore.
Conversely, nonspecific treatment response does not identify the cause. An animal may improve with rest and supportive care while still requiring a herd-control plan. Explain whether the purpose of testing is lesion diagnosis, assessment of previous exposure or eligibility for a particular breeding program.
Animal Health Ireland’s guidance emphasizes that clinical treatment varies with the actual problem and that latent infection cannot be removed by treatment or vaccination. Its program-specific advice should be interpreted in the relevant national setting.
Care protects damaged tissues and preserves welfare
Veterinary care may address pain, inflammation and any secondary complications. Antibiotics do not eliminate the herpesvirus itself. They should not be applied or injected indiscriminately in the hope that visible healing will establish freedom from infection.
Keep the animal in suitable clean conditions and prevent further painful mating while the clinician directs recovery. Do not apply caustic disinfectants or unapproved genital products. Reassessment is needed if urination, appetite or comfort worsens, or if the lesions do not follow the expected course.
Ask when the animal may return to breeding and what conditions must be met for that decision. The answer should include exposure risk, not only whether the skin now looks better.
Vaccination belongs within the herd-status plan
Vaccines can reduce disease and shedding, but do not guarantee prevention of infection or eliminate existing latency. Morocco’s official control-program explanation places vaccination alongside farm-risk management rather than presenting it as a stand-alone solution.
Product choice must fit pregnancy, previous vaccination and local disease-control rules. Some breeding-center or eradication programs impose particular conditions. Have the veterinarian check the applicable plan before vaccinating animals intended for those uses.
The cattle hub provides wider husbandry context. Reproductive infections such as trichomoniasis require separate tests and control; they are not ruled out by finding that BHV-1 is also present.
Can an animal carry the virus after the sores heal?
Yes. Latent infection can persist despite clinical recovery.
Is every genital ulcer in cattle caused by BHV-1?
No. Examination and appropriate testing must distinguish infection from trauma and other diseases.
Cite this reference
LivestockDefense. “BHV-1 genital disease in cattle: pustular vulvovaginitis and balanoposthitis.” Updated 2026-11-02. https://livestockdefense.com/threats/bovine-coital-exanthema/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Merck Veterinary Manual: Viral Infections Associated with Bovine Respiratory Disease Complex in Cattle
Source update: 2024-11. Most recent check: 2026-10-28.
Bounded BRSV clinical/diagnostic summary and brief adenovirus association; no copied treatment schedule.
- World Organisation for Animal Health: Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis
Source update: Not provided. Most recent check: 2026-10-28.
Respiratory mucosal replication, neuronal latency and availability of inactivated/attenuated vaccines; no product schedule.
- Friedrich-Loeffler-Institut: WOAH and national reference laboratory for bovine herpesvirus type 1 infection
Source update: Not provided. Most recent check: 2026-11-02.
Reference-laboratory description of genital and respiratory forms, lifelong persistence and suppression of genital spread through controlled artificial insemination.
- Animal Health Ireland: IBR in cattle: frequently asked questions
Source update: Not provided. Most recent check: 2026-11-02.
Latent infection cannot be removed by treatment/vaccination; vaccination and herd-status plans need professional assessment, particularly for breeding-center entry.
- Morocco National Office for Food Safety: IBR prophylaxis program
Source update: Not provided. Most recent check: 2026-11-02.
Vaccination reduces disease/shedding but does not prevent every infection or latent carrier; program must include farm-risk management.
